Visit Dr
There is no human trial of this exact combination, so the evidence here is built from studies on the individual components, most of it preclinical
Despite being sold by peptide suppliers, classification depends on chemistrynot on who sells it
Think of it as a two-part journey: a powerful initial push, followed by a steady, long-term cruise
investigated for selective fat-mobilising effects independent of GH receptor signalling Cartilage & joint research Examined in chondrocyte models and osteoarthritis frameworks for anabolic effects on cartilage matrix synthesis Metabolic profile Investigated for absence of the hyperglycaemic and IGF-1-elevating effects associated with full-length hGH, making it a useful tool compound for isolating GHs metabolic effects Body composition models Studied in rodent obesity models for changes in fat mass, lean mass, and energy expenditure Clinical research history Progressed to early-phase human trials in Australia (2000s) for obesity and osteoarthritis indications
However, it is unclear whether some facilities will continue to find ways to offer these alternative versions